Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Patscara who wrote (16973)	12/15/1998 10:40:00 PM
From: VLAD	Read Replies (2) \| Respond to of 23519

Where does it say that "PFE just lost 75% of the market to MUSE in just 6 weeks"?? If Viagra is not legally available in Canada then it is not losing any % of the market because it has none. The market Vivus is referring to is the market of ED products as reported by the IMS. Since Viagra is not sold in Canadian pharmacies it is not losing any market share. The 75% that MUSE captured obviously was taken from injection therapies that were available before MUSE became available. Sorry Pat, I'm not trying to give you a hard time. I was just trying to clarify the facts.

To: Patscara who wrote (16973)	12/15/1998 10:52:00 PM
From: Mkilloran	Respond to of 23519

pat....the news out of Canada is a good sign that Janssen is doing a good job of marketing Muse. We all want to share the news and the facts .. The fact is that Viagra is not forsale in Canada at this time. The bigger story is waiting to be published is out of Sweden where Muse and Viagra are being sold in the same market space. Muse sales in Sweden are down only 30% with the competition from Viagra and Astra is going after the Viagra failures .... This is the model that Astra and Janssen will duplicate in other countries around the world All we need now is a partner in the USA that can do the same. Waiting for ASTRA to strike at the right time with the data out of Sweden.